How activists play on our fears about pharmaceutical and biotech companies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Lhteenmki, R. & Lawrence, S. Nat. Biotechnol. 23, 663–671 (2005).
US National Institutes of Health. Today's Advances: The Result of Yesterday's Investments. FY 2000 Congressional Justification (NIH, Bethesda, MD, USA, 1999).
Wolfe, T.A. & Zycher, B. Biotechnological and Pharmaceutical Research and Development Investment Under a Patent-Based Access and Benefit-Sharing Scheme (Pacific Research Institute, San Francisco, 2005). http://www.pacificresearch.org/pub/sab/health/2005/ABS.pdf
Hofstadter R. The Paranoid Style in American Politics (University of Chicago Press, Chicago, 1952).
Author information
Authors and Affiliations
Author notes
He is the coauthor of The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution, chosen by Barron's as one of the 25 Best Books of 2004.
Rights and permissions
About this article
Cite this article
Miller, H. Activism unleashed...and unconscionable. Nat Biotechnol 24, 27–28 (2006). https://doi.org/10.1038/nbt0106-27
Issue Date:
DOI: https://doi.org/10.1038/nbt0106-27
This article is cited by
-
Privatizing biomedical research—a 'third way'
Nature Biotechnology (2008)